Mammoth Biosciences Raises $195 Million to Build Next-Generation CRISPR Products in Therapeutics and Diagnostics
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.
Study abroad platform Leap raises $ 55 million in Series C round led by Owl Ventures
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.
LEXEO Therapeutics Closes $100 Million Series B Financing to Advance Clinical Stage Gene Therapy Pipeline and Enhance Preclinical Footprint
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.
Evommune Inc., Completes $83 Million Series A Financing to Advance Development of Unique Chronic Inflammation Pipeline
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.
Thoma Bravo Makes Strategic Investment in Intel 471
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.
ATP Announces $40 Million in Series A Funding for srRNA Therapeutics Trailblazer Replicate Bioscience
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.
Eventus closes on $30 million Series B funding round
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.
Phil Sorgen Joins Tola Capital as Venture Partner
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.
ADARx Raises $75 Million to Advance Growing Pipeline
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.
Aviatrix Raises $200 Million in Funding Led by TCV, Elevating the Cloud Networking Leader’s Valuation to $2 Billion
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.